Demant gets FDA green light for new bone-anchored hearing solution

Oticon Medical, Demant's implants arm, has had its new bone-anchored product, Ponto 5 Superpower, cleared in the US. Following the FDA approval, the device is expected to be on shelves in spring.

The FDA has cleared Oticon's new product, Ponto 5 Superpower, which is a Bone Anchored Hearing System (BAHS) | Photo: Jens Dresling/Politiken/Ritzau Scanpix

The US Food and Drug Administration (FDA) has cleared Oticon Medical, Demant's implants arm, to market and sell its newest bone anchored hearing system (BAHS), a company press release announces.

Oticon's new product, Ponto 5 Superpower, is headed to the market in the coming spring when it will replace its predecessor, Ponto 5 Mini, which was launched by the Demant Group in 2021.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs